Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Dermatology

Free Subscription 29.06.2026 19 Am J Dermatopathol 1 Am J Pathol 35 BMC Cancer 3 Br J Dermatol 1 Cancer 14 Clin Exp Dermatol 2 Int J Cancer 1 Int J Dermatol 1 J Cutan Pathol 5 J Dermatol 18 J Invest Dermatol 1 J Laryngol Otol 1 JAAPA 6 Plast Reconstr Surg 9 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. MCFADDEN JR, Htoo A, Chaudhari AS, Stevanovic M, et al
   On the Progression From Early-to Late-Stage Melanoma: A Potential Sequence of Molecular Events Using Data From Droplet Digital PCR and Array Comparative Genomic Hybridization, A Pilot Study.
   Am J Dermatopathol. 2026 Jun 16. doi: 10.1097/DAD.0000000000003350.
   PubMed         Abstract available
   
   
2. BERTLICH I, Bertlich R, Arning AC, Bertlich M, et al
   Metastatic Syringocystadenocarcinoma Papilliferum Mimicking Cutaneous Squamous Cell Carcinoma of Unknown Primary in a Young Patient.
   Am J Dermatopathol. 2026 Jun 26. doi: 10.1097/DAD.0000000000003360.
   PubMed         Abstract available
   
   
3. OZDEN F, Coskun IS, Kasapgil I
   Melanoma Colonizing Basal Cell Carcinoma: A Rarely Described Entity.
   Am J Dermatopathol. 2026 Jun 11. doi: 10.1097/DAD.0000000000003348.
   PubMed         Abstract available
   
   
4. LENSKAYA V, Liu A, Nagarajan P, Aung PP, et al
   Case Series of Cutaneous Rothia Mucilaginosa Infection and an Important Potential Pitfall Case.
   Am J Dermatopathol. 2026 Jun 9. doi: 10.1097/DAD.0000000000003340.
   PubMed         Abstract available
   
   
5. GARAKANI R, Sejdiu Z, Kissinger CR, Alvarado LA, et al
   Determining the Association Between Clear Cell Acanthoma and Psoriasis: A Retrospective Case-Control Study.
   Am J Dermatopathol. 2026 May 27. doi: 10.1097/DAD.0000000000003327.
   PubMed         Abstract available
   
   
6. NGUYEN TT, Otsuki S, Ito H, Fujimoto M, et al
   Granulation Tissue-Like Spindle Cell Squamous Cell Carcinoma of the Skin Arising in a Burn Scar.
   Am J Dermatopathol. 2026 Jun 2. doi: 10.1097/DAD.0000000000003333.
   PubMed         Abstract available
   
   
7. TAKEUCHI M, Kaku Y, Hashikawa K, Tominaga M, et al
   Adult Sibling Cases of Cutaneous Botryomycosis Leading to the Diagnosis of X-Linked Agammaglobulinemia.
   Am J Dermatopathol. 2026 May 14. doi: 10.1097/DAD.0000000000003306.
   PubMed         Abstract available
   
   
8. SRON D, Hayes C, Chan J, Ardakani NM, et al
   Expanding the Spectrum of Cutaneous ALK Fusion Mesenchymal Tumors: A Case with Unique Histological Features.
   Am J Dermatopathol. 2026 Jun 2. doi: 10.1097/DAD.0000000000003332.
   PubMed         Abstract available
   
   
9. SHAKER N, Phelps R, Torres-Cabala C, Niedt G, et al
   Erratum: Cutaneous Involvement by Diffuse Large B-Cell Lymphoma With Dual B-Cell and T-Cell Clonality and Heavy Admixed T-Cell Infiltrate: Answer.
   Am J Dermatopathol. 2026 Feb 25. doi: 10.1097/DAD.0000000000003250.
   PubMed        
   
   
10. ABDELHAMMED MH, Yu H, Ramani NS
    Desmoplastic Trichilemmoma Mimicking Basal Cell Carcinoma: Two New Cases, Systematic Review of 92 Cases and Dual Staining Diagnostic Approach.
    Am J Dermatopathol. 2026 May 20. doi: 10.1097/DAD.0000000000003322.
    PubMed         Abstract available
    
    
11. RULEY AJ, Moran SK, Blankenship HT, Martinez S, et al
    Utility of p16, p21, and PRAME Immunohistochemistry in Melanocytic Lesions.
    Am J Dermatopathol. 2026 May 20. doi: 10.1097/DAD.0000000000003326.
    PubMed        
    
    
12. KAZMI M, Melloy MP, Abukhadra S, Terrell JR, et al
    Observational Study Profiling the Immune Microenvironment of Pregnancy-associated Melanoma.
    Am J Dermatopathol. 2026 Jun 10. doi: 10.1097/DAD.0000000000003335.
    PubMed        
    
    
13. SHAKER N, Phelps R, Torres-Cabala C, Niedt G, et al
    Erratum: Navigating the Complexity of Dual Clonality in Cutaneous Lymphoma: Challenge.
    Am J Dermatopathol. 2026 Feb 27. doi: 10.1097/DAD.0000000000003249.
    PubMed        
    
    
14. NAKAZATO S, Takakuwa E, Minagawa T, Anan T, et al
    Malignant Mixed Tumor of the Skin With TRPS1::PLAG1 Fusion.
    Am J Dermatopathol. 2026 Jun 8. doi: 10.1097/DAD.0000000000003343.
    PubMed         Abstract available
    
    
15. HUANG EB, Dadras SS
    Lymphatic Phenotype Predominates in Cutaneous Kaposi Sarcoma: A Dual Immunohistochemical Analysis of HHV8-Positive Cells.
    Am J Dermatopathol. 2026 May 12. doi: 10.1097/DAD.0000000000003319.
    PubMed         Abstract available
    
    
16. TOUSSAINT AL, Sanchez-Cardenas C, Fuentes-Garcia R, Charli-Joseph Y, et al
    PRAME Immunostaining in Acral Melanocytic Proliferations: A Meta-Analysis.
    Am J Dermatopathol. 2026 May 12. doi: 10.1097/DAD.0000000000003299.
    PubMed         Abstract available
    
    
17. HAMILTON L, Bourgeois JC, Johnson K, Jimenez A, et al
    Primary Cutaneous Rosai-Dorfman Disease Presenting as an Infiltrative Dorsal Nasal Mass With Deep Skeletal Muscle Involvement.
    Am J Dermatopathol. 2026 Jun 24. doi: 10.1097/DAD.0000000000003358.
    PubMed         Abstract available
    
    
18. FUKUDA K, Mitsui Y, Ogawa K, Morita K, et al
    Collision Tumor of Basal Cell Carcinoma and Primary Extramammary Paget Disease: A Case Report and Literature Review.
    Am J Dermatopathol. 2026 Jun 24. doi: 10.1097/DAD.0000000000003368.
    PubMed         Abstract available
    
    
19. HELM TN, Lam C, Zoshchuk B, Helm MF, et al
    PRAME Expression and Melanoma In Situ Margin Assessment.
    Am J Dermatopathol. 2026 Jun 22. doi: 10.1097/DAD.0000000000003349.
    PubMed         Abstract available
    
    

    
    Am J Pathol

20. HLADIK C, Sekhri M, Cen HH, Elayapillai SP, et al
    Spatially Resolved Obesity-Driven Molecular Changes in Early Breast Cancer.
    Am J Pathol. 2026 Apr 30:S0002-9440(26)00124.
    PubMed         Abstract available
    
    

    
    BMC Cancer

21. LI H, Chen Y, Guo G, Luo Q, et al
    PPP4C: a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer.
    BMC Cancer. 2026 May 4. doi: 10.1186/s12885-026-16083.
    PubMed         Abstract available
    
    
22. CAZZANIGA ME, Galimberti S, Pepe FF, Cogliati V, et al
    Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study.
    BMC Cancer. 2026 Jan 20. doi: 10.1186/s12885-025-15482.
    PubMed        
    
    
23. ELALFY E, Gaber NE, Helmy MH, Kamel MA, et al
    Scrutinizing the potential role of non-coding RNAs as biomarkers in Egyptian females with early and metastatic breast cancer.
    BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-025-15483.
    PubMed        
    
    
24. YOON TI, Baek S, Lee JH, Yoo TK, et al
    Clinical significance of peripheral blood parameters as a prognostic biomarker in patients receiving neoadjuvant chemotherapy for breast cancer.
    BMC Cancer. 2026 Jan 3. doi: 10.1186/s12885-025-15510.
    PubMed        
    
    
25. WEI C, Zhou S, Zhu L, Kong J, et al
    Comparison of the efficacy between radiotherapy alone and surgery plus radiotherapy for ipsilateral supraclavicular lymph node metastasis in breast cancer based on propensity score matching analysis: a retrospective study with 8-year follow-up.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15424.
    PubMed        
    
    
26. XIE H, Zhang J, Li Q, Tan T, et al
    Enhancing breast cancer diagnosis: non-invasive prediction of MKI-67 (Ki67) expression using ultrasound images.
    BMC Cancer. 2025 Dec 15. doi: 10.1186/s12885-025-15443.
    PubMed         Abstract available
    
    
27. FESSI Z, Bonnier S, Lodyga K, Wallet J, et al
    Stereotactic re-irradiation for lymph node recurrence of breast cancer.
    BMC Cancer. 2025 Dec 8. doi: 10.1186/s12885-025-15418.
    PubMed        
    
    
28. DA COSTA NC, Fernandes ACP, Damin APS
    Prognostic relevance of increased tumor-infiltrating lymphocytes in residual TNBC following neoadjuvant chemotherapy.
    BMC Cancer. 2025;25:1856.
    PubMed         Abstract available
    
    
29. SARFRAZ Z, Ozair A, Bardhan M, Starosciak AK, et al
    Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial.
    BMC Cancer. 2025 Dec 4. doi: 10.1186/s12885-025-15224.
    PubMed         Abstract available
    
    
30. DU R, Qian R, Qin R, Yu Y, et al
    Gradient perfusion features can effectively identify sentinel lymph node metastasis in early breast cancer.
    BMC Cancer. 2025 Dec 1. doi: 10.1186/s12885-025-15251.
    PubMed        
    
    
31. PETER J, Jolly B, Raha R, Jothi J, et al
    Germline mutational landscape in a large cohort of Indian breast cancer.
    BMC Cancer. 2025 Dec 1. doi: 10.1186/s12885-025-15360.
    PubMed        
    
    
32. MALAWARAARACHCHI BP, Abeysinghe C, Seneviwickrama M, Ranasinghe S, et al
    Body image concerns among women diagnosed with breast cancer in a South Asian setting: a phenomenology approach.
    BMC Cancer. 2025;25:1819.
    PubMed         Abstract available
    
    
33. GERSHFELD-LITVIN A, Shay-Peretz N, Hanalis-Miller T
    Motherhood with HBOC in Israel: experiencing preventive disruption.
    BMC Cancer. 2025;25:1928.
    PubMed         Abstract available
    
    
34. LYU Q, Yuan H, Lin Z, Barcus R, et al
    A large scale multi-dataset investigation of brain metastases distribution based on primary cancer type.
    BMC Cancer. 2025;25:1821.
    PubMed         Abstract available
    
    
35. SENDUR MAN, Hizal M, Cakar B, Aktepe OH, et al
    Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.
    BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15287.
    PubMed        
    
    
36. DELABY C, Al Herk A, Hirtz C, Jacot W, et al
    Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer.
    BMC Cancer. 2025;25:1801.
    PubMed         Abstract available
    
    
37. YU S, Wu J
    CTHRC1-driven breast cancer progression: insights from palmitoylation networks and spatial heterogeneity.
    BMC Cancer. 2025;25:1795.
    PubMed         Abstract available
    
    
38. CHEN Q, Xiong J, Wang H, Xu Y, et al
    A nomogram for breast cancer brain metastasis patients after stereotactic radiotherapy.
    BMC Cancer. 2025;25:1784.
    PubMed         Abstract available
    
    
39. ELSNER SA, Haussmann E, Grieger P, Hadwiger M, et al
    Optimising breast cancer screening in national mammography screening centres: challenges and insights on implementing additional ultrasound for women with dense breast tissue - a qualitative study.
    BMC Cancer. 2025;25:1684.
    PubMed        
    
    
40. ZAFAR S, Badshah Y, Shabbir M, Khan S, et al
    Comprehensive computational analysis of PKCdelta non-synonymous variants identifies rs1703863535 as a potential breast cancer biomarker.
    BMC Cancer. 2025;25:1667.
    PubMed         Abstract available
    
    
41. DERISMAHAFI Z, Farhud D, Razavirad A, Muhammadnejad A, et al
    NRF2 expression level and estrogen function in BRCA1-mutated breast cancer.
    BMC Cancer. 2025;25:1622.
    PubMed         Abstract available
    
    
42. LI L, Yang P, Hong C, Chen D, et al
    Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response and prognosis in breast cancer: a multicenter retrospective study based on Chinese population.
    BMC Cancer. 2025;25:1585.
    PubMed         Abstract available
    
    
43. OKAZAKI M, Ueda A, Iguchi-Manaka A, Mathis BJ, et al
    Refining compression therapy for the prevention of chemotherapy-induced peripheral neuropathy in breast cancer patients: a sub-analysis of patient-reported discomfort and usability.
    BMC Cancer. 2025;25:1567.
    PubMed         Abstract available
    
    
44. FATHIMA ZS, Suresh TNR, Kattepur AK
    Immunohistochemical expression of tumor-infiltrating lymphocytes CD8 and FOXP3 in invasive ductal carcinoma of breast.
    BMC Cancer. 2025;25:1550.
    PubMed         Abstract available
    
    
45. TAKADA K, Kashiwagi S, Nishikawa M, Kochi A, et al
    Differences in Sentinel lymph node biopsy outcomes and prognosis between HER2-low and HER2-zero breast cancer.
    BMC Cancer. 2025;25:1518.
    PubMed         Abstract available
    
    
46. HOSSEINI SS, Askari N, Yaghoobi MM
    Combined anti-tumor effects of metformin and azacitidine in breast cancer cells.
    BMC Cancer. 2025;25:1487.
    PubMed         Abstract available
    
    
47. CHEN X, Cheng Z, Li Y, Wu X, et al
    Development and validation of a machine learning model to predict delays in seeking medical care among patients with breast cancer in China.
    BMC Cancer. 2025;25:1442.
    PubMed         Abstract available
    
    
48. KURANT DE, Groha S, Ding Y, German C, et al
    Association between polygenic risk and survival in breast cancer patients.
    BMC Cancer. 2025;25:1393.
    PubMed        
    
    
49. TAFESE AM, Fentie MT, Seifu BL, Asnake AA, et al
    Breast cancer survival rates and determinants in Ethiopia: a systematic review and meta-analysis of longitudinal studies.
    BMC Cancer. 2025;25:1263.
    PubMed         Abstract available
    
    
50. SHARIATMADARI H, Taheri-Kharameh Z, Kamaliuon N, Ghanbari Hashem Abadi BA, et al
    Comparing the effectiveness of gratitude intervention and behavioral activation technique in breast cancer patients: a randomized trial.
    BMC Cancer. 2025;25:1226.
    PubMed         Abstract available
    
    
51. CHAI C, Shao K, Shan G, Li P, et al
    Dosimetric study of TrueBeam single-isocenter vs. Halcyon dual-isocenter VMAT radiotherapy plans for postoperative left-sided breast cancer.
    BMC Cancer. 2025;25:1214.
    PubMed         Abstract available
    
    
52. HENDY A, Ibrahim RK, Darwish A, Al Sabbah S, et al
    Sleep disturbance, cancer-related fatigue, and depression as determinants of quality of life among breast cancer patients undergoing chemotherapy: a cross-sectional study.
    BMC Cancer. 2025;25:1122.
    PubMed         Abstract available
    
    
53. CIVIL YA, Duvivier KM, Bartels SAL, Velde SV, et al
    Impact of neoadjuvant systemic therapy on surgical and radiotherapy outcomes in patients with early-stage breast cancer: a cross-sectional retrospective single-center study.
    BMC Cancer. 2025;25:1046.
    PubMed         Abstract available
    
    
54. GOERG A, Piendl G, Albert V, Ortmann O, et al
    Mdm2 targeting via PROteolysis TArgeting Chimeras (PROTAC) is efficient in p53 wildtype, p53-mutated, and abemaciclib-resistant estrogen receptor-positive cell lines and superior to mdm2 inhibition.
    BMC Cancer. 2025;25:978.
    PubMed         Abstract available
    
    
55. HU B, Shi C, Qi M, Ding A, et al
    Exploring the immune landscape and immunotherapy relevance of ER stress-related lncRNAs in melanoma through multi-omics and explainable machine learning.
    BMC Cancer. 2026 Jun 19. doi: 10.1186/s12885-026-16356.
    PubMed         Abstract available
    
    

    
    Br J Dermatol

56. AGELOPOULOS K, Nattkemper L, Witte F, Zeidler C, et al
    Dupilumab treatment restores skin nerve fibre density in patients with moderate-to-severe atopic dermatitis: results from DIFFERENSTAD, an open-label exploratory study.
    Br J Dermatol. 2026 Jun 23:ljag256. doi: 10.1093.
    PubMed        
    
    
57. YANG L, Li L, Mao J, Liang Q, et al
    Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment.
    Br J Dermatol. 2026 Jun 22:ljag258. doi: 10.1093.
    PubMed         Abstract available
    
    
58. MAO G, Lan H
    Comment on 'Ethnicity and the epidemiology of skin cancer incidence: a national retrospective population-based study in England, 2013-20'.
    Br J Dermatol. 2026 Jun 22:ljag168. doi: 10.1093.
    PubMed        
    
    

    
    Cancer

59. MA VT, Steimle AK, Patel JD, Burkey C, et al
    Updates on intratumoral therapies in melanoma.
    Cancer. 2026;132:e70400.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

60. JOSHI S, Carey B, Thakrar I, Setterfield J, et al
    Oral manifestations of lupus erythematosus.
    Clin Exp Dermatol. 2026;51:1241-1246.
    PubMed         Abstract available
    
    
61. MO S, Nguyen J, Wang CY, Curnow P, et al
    Intravenous immunoglobulin as a therapy for severe or steroid-recalcitrant erythema multiforme major: a case series.
    Clin Exp Dermatol. 2026;51:1276-1280.
    PubMed         Abstract available
    
    
62. MASOOD M, Lane B, Maghfour J, Ceresnie M, et al
    The efficacy of tranexamic acid in prevention and treatment of post-inflammatory hyperpigmentation: a pilot study.
    Clin Exp Dermatol. 2026;51:1272-1275.
    PubMed         Abstract available
    
    
63. NARAYAN R V, Thakur V, Bishnoi A, Sarkar R, et al
    Acquired dermal macular hyperpigmentation: a unified spectrum of dermal pigmentary dermatoses.
    Clin Exp Dermatol. 2026;51:1213-1224.
    PubMed         Abstract available
    
    
64. SUSANTO A, Morgan E, Lindsay D, Collins LG, et al
    Chemoprevention of keratinocyte carcinomas and actinic keratoses in adults who were immunocompetent: a systematic review.
    Clin Exp Dermatol. 2026;51:1202-1212.
    PubMed         Abstract available
    
    
65. RIDD MJ, Stuart B, Santer M, Granell R, et al
    Consultations, prescribed topical treatments and disease severity in children with eczema in primary care: analysis of electronic medical records in the BATHE study.
    Clin Exp Dermatol. 2026;51:1255-1262.
    PubMed         Abstract available
    
    
66. VINAY K, Singh S, Choudhary R, Bishnoi A, et al
    Clinical and prognostic implications of erythema multiforme-like lesions in patients with drug reaction with eosinophilia and systemic symptoms: a prospective case-control study.
    Clin Exp Dermatol. 2026;51:1235-1240.
    PubMed         Abstract available
    
    
67. KAUR S, Raj RT, Narang T
    Repurposing itraconazole in clinical dermato-oncology beyond conventional antifungal use: a review.
    Clin Exp Dermatol. 2026;51:1191-1201.
    PubMed         Abstract available
    
    
68. JING X, Huang X, He S, Lu Y, et al
    Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.
    Clin Exp Dermatol. 2026 Jun 26:llag276. doi: 10.1093.
    PubMed        
    
    
69. NAPOLITANO M, Palagiano C, Patruno C, Turco M, et al
    Treatment Trajectories and Dose Optimization of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A Real-World Landmark Analysis.
    Clin Exp Dermatol. 2026 Jun 26:llag271. doi: 10.1093.
    PubMed         Abstract available
    
    
70. ECHEANDIA-FRANCIS C, Luo AJ, Jiang X, Soltani H, et al
    Cutaneous features of SDR9C7 variants in eight subjects with autosomal recessive nonsyndromic epidermal differentiation disorders.
    Clin Exp Dermatol. 2026 Jun 24:llag270. doi: 10.1093.
    PubMed         Abstract available
    
    
71. CAPPER I, Hughes A
    A Review of Male Genital Psoriasis.
    Clin Exp Dermatol. 2026 Jun 24:llag261. doi: 10.1093.
    PubMed         Abstract available
    
    
72. RAJPUT J, Ogieva E, Parkar R
    Evaluation of the cost effectiveness of three-monthly whole-body positron emission tomography-computed tomography (PET-CT) surveillance scans for the identification of melanoma recurrence.
    Clin Exp Dermatol. 2026 Jun 21:llag266. doi: 10.1093.
    PubMed        
    
    
73. HASSAN MWU
    The purpura-like pattern in lower-limb basal cell carcinoma: accounting for venous stasis as a confounding factor.
    Clin Exp Dermatol. 2026 Jun 20:llag259. doi: 10.1093.
    PubMed        
    
    

    
    Int J Cancer

74. ANDOUR L, Hagenaars SC, de Groot AF, Krol-Warmerdam EMM, et al
    The Predictive Value of the Tumor-Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer.
    Int J Cancer. 2026 Apr 10. doi: 10.1002/ijc.70490.
    PubMed         Abstract available
    
    
75. CHOKUNONGA E, Chirenje ZM, Borok M, Makunike-Mutasa R, et al
    Trends in the incidence of cancers of the breast and female genital tract in Harare, Zimbabwe 1990-2019.
    Int J Cancer. 2026;159:844-852.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

76. KOUMPRENTZIOTIS IA, Tsiogka A, Kleidona IA, Vaiopoulos A, et al
    Sustained Minimal Disease Activity With Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 104-Week, Real-World, Retrospective Study.
    Int J Dermatol. 2026 Jun 25. doi: 10.1111/ijd.70558.
    PubMed        
    
    

    
    J Cutan Pathol

77. SEVERIN S, Boostani M, Salloum L, Bozsanyi S, et al
    Evaluating Large Language Models for Melanocytic Lesion Pathology Report Interpretation.
    J Cutan Pathol. 2026 Jun 25. doi: 10.1111/cup.70121.
    PubMed        
    
    

    
    J Dermatol

78. NISHIMURA K, Oyama N, Hasegawa T, Kasamatsu H, et al
    A Serum N-Glycan Ratio Associated With Disease Severity and Treatment Response in Psoriasis.
    J Dermatol. 2026 Jun 23. doi: 10.1111/1346-8138.70316.
    PubMed         Abstract available
    
    
79. MORI T, Otsuka M, Yamamoto T
    Therapeutic Effectiveness of Radiotherapy for Lymph Node Metastases of Cutaneous Squamous Cell Carcinoma: A Single-Center Retrospective Analysis.
    J Dermatol. 2026 Jun 23. doi: 10.1111/1346-8138.70363.
    PubMed         Abstract available
    
    
80. PARK JY, Lee HJ, Huh CH
    A Case of SREBF1-Associated Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome With Recurrent Alopecia.
    J Dermatol. 2026 Jun 23. doi: 10.1111/1346-8138.70360.
    PubMed        
    
    
81. HU ZM, He W, Hu B, Zou L, et al
    Cutaneous and Subcutaneous Hyalohyphomycosis Caused by Purpureocillium Lilacinum in a Tertiary Referral Hospital in Central China.
    J Dermatol. 2026 Jun 22. doi: 10.1111/1346-8138.70366.
    PubMed         Abstract available
    
    
82. MAKINO T, Takemoto K, Mizawa M, Shimizu T, et al
    Platelet-Rich Plasma Therapy for Refractory Skin Ulcers: A Case Series of 12 Patients and Concise Review of the Literature.
    J Dermatol. 2026 Jun 19. doi: 10.1111/1346-8138.70365.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

83. YANG Y, Xu Z, Wu X, Xuan Y, et al
    Clinical characteristics, outcome, and costs among patients in a dermatological intensive care unit: A single-center retrospective study.
    J Invest Dermatol. 2026;146:1887-1895.
    PubMed         Abstract available
    
    
84. CECCACCI S, Roger K, Marchal L, Ragot H, et al
    Proteomics reveals altered lipid biosynthesis and keratin hyperphosphorylation in pachyonychia congenita.
    J Invest Dermatol. 2026;146:1906-1917.
    PubMed         Abstract available
    
    
85. PEACKER BL, Ly L, Hwang JC, Gravel-Pucillo K, et al
    Multiomics analyses prioritize disease genes and pathways in hidradenitis suppurativa.
    J Invest Dermatol. 2026;146:1807-1815.
    PubMed         Abstract available
    
    
86. WANG Y, Qin D, Jiang X, Yin D, et al
    Inhibitory regulation of itch and associated negative emotions by ventral hippocampal neurons in rats.
    J Invest Dermatol. 2026;146:1930-1944.
    PubMed         Abstract available
    
    
87. DIAZ D, Vazquez T, Kodali N, Bashir MM, et al
    Lenabasum, a cannabinoid type 2 receptor agonist, exerts anti-inflammatory effects in dermatomyositis.
    J Invest Dermatol. 2026;146:1827-1836.
    PubMed         Abstract available
    
    
88. HE T, Wang Y, Yu G, Dong E, et al
    Myeloid-driven inflammation highlights ADGRE2 as a biomarker in prurigo nodularis: Integrated multiomics analysis.
    J Invest Dermatol. 2026;146:1918-1929.
    PubMed         Abstract available
    
    
89. LIM SS, Zhao P, Wong NC, Szeto P, et al
    Evaluation of clonality in lentigo maligna.
    J Invest Dermatol. 2026;146:1955-1965.
    PubMed         Abstract available
    
    
90. WANG Y, Wang Z, Lv S, Huang Q, et al
    OCA2 deficiency enhances TPC2 channel activity to reduce melanosomal pH and pigment production.
    J Invest Dermatol. 2026;146:2001-2015.
    PubMed         Abstract available
    
    
91. DORFER S, Zauner R, Guttmann-Gruber C, Reichl V, et al
    Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.
    J Invest Dermatol. 2026;146:1978-1988.
    PubMed         Abstract available
    
    
92. SENNETT ML, Feehan RP, Wallace TE, Gettle SL, et al
    Connectivity mapping with isotretinoin's transcriptomic signature identifies alternative therapeutics for severe acne.
    J Invest Dermatol. 2026;146:1876-1886.
    PubMed         Abstract available
    
    
93. ELSBROEK L, Reuschlein K, Karsai S, Geueke A, et al
    Primary keratinocyte model of actinic keratosis reveals UV-induced DNA damage accumulation and persistent IFN signaling.
    J Invest Dermatol. 2026;146:1837-1850.
    PubMed         Abstract available
    
    
94. PANDYA AG, Lynde CW, Shayesteh Alam M, Thorla IH, et al
    Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo.
    J Invest Dermatol. 2026;146:1867-1875.
    PubMed         Abstract available
    
    
95. WILLIAMS MN, Joffe D, Mandel J, Schepps S, et al
    Spatial transcriptomics uncovers unique tumor microenvironments in folliculotropic versus classic mycosis fungoides.
    J Invest Dermatol. 2026;146:1945-1954.
    PubMed         Abstract available
    
    
96. SEISER S, Brezovec H, Penninger P, Phan-Canh T, et al
    Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02659.
    PubMed         Abstract available
    
    
97. SHAKIBA S, Okinedo I, Salam N, Li M, et al
    Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02657.
    PubMed         Abstract available
    
    
98. CASSIDY PB, Berry EG, Samatham R, Mengden S, et al
    The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02625.
    PubMed         Abstract available
    
    
99. ARMSTRONG AW, Roberts AM, Kostandy G, Choudhury F, et al
    Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02656.
    PubMed         Abstract available
    
    
100. LV M, Yang F, Jiang C, Man XY, et al
     Cellular immunotherapy in psoriasis: Chimeric antigen receptor-based strategies and emerging approaches to immune reset.
     J Invest Dermatol. 2026 Jun 20:S0022-202X(26)01268.
     PubMed        
     
     

     
     J Laryngol Otol

101. SATTAR Z, Mowat A, Barraclough J
     Septal melanoma: does surgical excision confer a potential survival benefit? A single centre's experience and literature review.
     J Laryngol Otol. 2026 Jun 23:1-20. doi: 10.1017/S0022215126105283.
     PubMed        
     
     

     
     JAAPA

102. MIDDLETON HT, Young PA, Kolhoff S, Tapia AL, et al
     Use of dermoscopy and its association with skin lesion evaluation confidence among PAs in the United States.
     JAAPA. 2026;39:e13-e19.
     PubMed         Abstract available
     
     

     
     Plast Reconstr Surg

103. MARCO E, Liaqat A, Shamoun F, Hosseini B, et al
     Impact of Breast Cancer Surgery on Physical Well-Being of the Chest: A Longitudinal BREAST-Q Study.
     Plast Reconstr Surg. 2026;158:27-36.
     PubMed         Abstract available
     
     
104. CHA HG, Kang YH, Choi E, Park HW, et al
     Mini Free Flaps for Diabetic Foot Reconstruction.
     Plast Reconstr Surg. 2026;158:155e-163e.
     PubMed         Abstract available
     
     
105. GARVEY PB, Larsen AN, Skoracki RJ, Djohan RS, et al
     Larger-Volume Silicone Breast Implants Are Safe in Breast Reconstruction: The Athena Multicenter Prospective Study of 400 Patients.
     Plast Reconstr Surg. 2026;158:10-23.
     PubMed         Abstract available
     
     
106. SHAMMAS RL, Boe LA, Wagner BD, Chen J, et al
     Optimal Timing of Expander-to-Implant Exchange after Postmastectomy Radiation Therapy: 90-Day Complications and Patient-Reported Outcomes.
     Plast Reconstr Surg. 2026;158:8e-16e.
     PubMed         Abstract available
     
     
107. GEHRING MB, Wolfe B, Kalia N, Helmkamp LJ, et al
     Comparing Discharge Timing in Patients Undergoing Immediate Implant-Based Breast Reconstruction: A Randomized Controlled Trial.
     Plast Reconstr Surg. 2026;158:1-9.
     PubMed         Abstract available
     
     
108. GUR Z, Shoji MK, Dib El Jalbout N, Liu CY, et al
     Reconstruction of Large Full-Thickness Medial Lower Eyelid Defects Using a Medially Based Tarsoconjunctival Pedicle Flap.
     Plast Reconstr Surg. 2026;158:138e-141e.
     PubMed         Abstract available
     
     

     
     PLoS One

109. LIN Y, Hong Z, Xie W, Lu A, et al
     Ultrasound-guided microwave ablation versus conventional surgery for Granulomatous Lobular Mastitis: A two-center retrospective comparative stud.
     PLoS One. 2026;21:e0351776.
     PubMed         Abstract available
     
     
110. PHAM TT, Vu MN, Le MH, Le DH, et al
     Plasma C5a and serum C5aR levels in patients with chronic spontaneous urticaria: A single-center case-control study.
     PLoS One. 2026;21:e0351329.
     PubMed         Abstract available
     
     
111. JEFFERSON RS, Bentley-Spuur KM, Chinkwo K, Singh CL, et al
     A curriculum-integrated sun safety intervention to improve adolescent skin health knowledge in an independent girls' secondary school.
     PLoS One. 2026;21:e0350659.
     PubMed         Abstract available
     
     
112. KHAN MM, Hossain MA, Zohora F, Sohel M, et al
     In silico screening and molecular analyses identify apigenin from Scutellaria barbata as a potent AKT1 inhibitor in breast cancer.
     PLoS One. 2026;21:e0338874.
     PubMed         Abstract available
     
     
113. JIN H, Liu E, Xu Q, Li Y, et al
     Few-shot skin lesion classification with Adaptive Multi-Scale Convolutional Attention Network.
     PLoS One. 2026;21:e0351318.
     PubMed         Abstract available
     
     
114. RAMPAL S, Lopes CA, Hadi P, Neela VK, et al
     Risk factors associated with diabetic foot amputation: A retrospective study from a tertiary hospital in Central Malaysia.
     PLoS One. 2026;21:e0335328.
     PubMed         Abstract available
     
     
115. AHMED J, Matthews C, Tulloch P, Lawler W, et al
     TNFR2 is expressed by a discrete subset of epidermal T cells with an IL-17 gene signature during psoriasis.
     PLoS One. 2026;21:e0351508.
     PubMed         Abstract available
     
     
116. NEMET B, Varga BA, Kiss N, Cakir U, et al
     Reliability and construct validity of the Hungarian version of Skindex-Mini.
     PLoS One. 2026;21:e0350749.
     PubMed         Abstract available
     
     
117. PHETDEE C, Naephrai S, Pradain M, Panporm Y, et al
     Synergistic anticancer activity of antimicrobial peptide nisin and doxorubicin against breast cancer cells via modulation of membrane permeability.
     PLoS One. 2026;21:e0352312.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

118. BU W, Lee TD, Anurag M, Dou Y, et al
     Rat somatic genome editing enables ER+ breast cancer modeling.
     Proc Natl Acad Sci U S A. 2026;123:e2529653123.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum